The survey assessed vaccine provider behaviors and attitudes regarding pneumococcal vaccine recommendations and knowledge of the recommendations.
All articles by Diana Ernst, RPh
Gardasil 9 (HPV 9-valent vaccine, recombinant) was associated with sustained antibody responses at 10 years among boys and girls who received a 3-dose regimen at 9 to 15 years of age.
The Advisory Committee on Immunization Practices has issued new guidelines for the prevention and control of seasonal influenza with vaccines for the 2023-2024 season.
The FDA has approved the sNDA for Veklury to include COVID-19 treatment in patients with mild to severe hepatic impairment with no dose adjustments.
Preexposure prophylaxis should be prescribed to individuals at risk of acquiring HIV to prevent HIV, according to the USPSTF.
The FDA has approved Abrysvo (respiratory syncytial virus vaccine) for active immunization of pregnant individuals to prevent RSV disease in infants.
Moderna’s updated COVID-19 vaccine was found to generate a significant immune response against widely circulating variants, EG.5 and FL 1.5.1.
The FDA has issued a safety communication regarding tests manufactured by Universal Meditech, Inc.
The FDA has approved Prevymis (letermovir) from 100 to 200 days in adults receiving an allogeneic HSCT who are at risk for late CMV infection and disease.
The FDA has approved Zurzuvae (zuranolone) for the treatment of postpartum depression in adults.
A phase 1/2 trial is evaluating the gene therapy in adult patients with HIV-1 who are on stable ART.
Issues related to data collection that could not be addressed within the review period led to the withdrawal of the application.
The investigational RSV vaccine consists of a single mRNA sequence encoding for a stabilized prefusion F glycoprotein.
There are currently no vaccines approved for preventing Neisseria gonorrhoeae infection.
The supply issues is compounded by a recent recall of non-sterile disposable tourniquet cuffs.
The last lots of the vaccine purchased by the US government have expired.
The combination antibiotic consists of aztreonam, a monobactam β-lactam and avibactam, a broad-spectrum β-lactamase inhibitor.
The is the first approval of an oral antiviral therapy for COVID-19.
Xacduro is a co-packaged product containing sulbactam, a beta-lactam antibacterial and beta lactamase inhibitor, and durlobactam, a beta lactamase inhibitor.
Children who ingest the incorrect product are at increased risk of serious adverse events.
LMN-201 combines 4 therapeutic proteins that act synergistically.
Affected patients underwent procedures in Matamoros, Mexico.
There are currently no FDA-approved therapeutics for BKV infection.
Treatment-emergent adverse events (grade 3 or higher) were reported to be similar between groups.
Bemnifosbuvir is currently being evaluated in the phase 3 SUNRISE-3 trial, which includes high-risk outpatients with COVID-19.
The test aids in the diagnosis of symptomatic or asymptomatic infections with C. trachomatis, N. gonorrhoeae, and T. vaginalis.
In immunocompromised individuals, the use of contaminated product could potentially lead to life-threatening infections.
Earlier this month, Global Pharma Healthcare had announced a nationwide recall of its artificial tear lubricant eye drops distributed by EzriCare, LLC and Delsam Pharma.
Rezafungin is an investigational echinocandin antifungal that is administered once weekly.